Teriparatide Enhancement of Lumbar Fusion: Bone Enhancement Versus Cost, Convenience, and Risk of CancerCommentary on an article by Shigeto Ebata, MD, PhD, et al. “Role of Weekly Teriparatide Administration in Osseous Union Enhancement within Six Months After Posterior or Transforaminal Lumbar Interbody Fusion for Osteoporosis-Associated Lumbar Degenerative Disorders. A Multicenter, Prospective Randomized Study”

    loading  Checking for direct PDF access through Ovid


Abstract unavailable for this article.

    loading  Loading Related Articles